Impact BioMedical, Inc.

IBOAMEX • USD
4.91 USD
↘ 0.23 (4.47%)AT CLOSE (03:59 PM EST)
4.92
↗ 0.01 (0.10%)
POST MARKET (AS OF 08:15 PM EST)
Post Market
AS OF 08:15 PM EST
4.92
↗ 0.01 (0.10%)
🔴Market: CLOSED

Impact BioMedical, Inc. (IBO) trades at $4.91 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9 and a bearish Death Cross on the long-term moving averages. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 16, 2026.

Open?$5.13
High?$5.15
Low?$4.90
Prev. Close?$5.14
Volume?13.0K
Avg. Volume?15.9K
VWAP?$5.08
Rel. Volume?0.81x
Bid / Ask
Bid?$4.30 × 800
Ask?$5.20 × 100
Spread?$0.90
Midpoint?$4.75
Valuation & Ratios
Market Cap?44.4M
Shares Out?8.5M
Float?995.3K
Float %?11.5%
P/E Ratio?27.52
P/B Ratio?4.39
EPS?$0.19
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Employees
8
Market Cap
44.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-09-16
Address
275 WIREGRASS PKWY,
WEST HENRIETTA, NY 14586
Phone: 585 232 1500
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
73
Momentum?
71
Short Sent.?
75
Piotroski F-Score?2/9Weak
Altman Z-Score?3.05Safe
Confidence?53%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.47%Low
Short Interest?24.6K
Days to Cover?1.2
Free Float995.3K
Avg Daily Volume21.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.04Weak
Quick Ratio?0.02Weak
Cash Ratio?0.01Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
56/100
P/E?
Peers
100
S&P
41
27.5FAIR▾
P/B?
Peers
100
S&P
41
4.39FAIR▾
P/S?
Peers
100
S&P
3
1,168.67HIGH▾
P/FCF?
Peers
100
S&P
3
382.8PRICEY▾
EV/EBITDA?
S&P
97
-12.1CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,168.12HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
57
16.0%STRONG▾
ROA?
Peers
50
S&P
74
9.8%STRONG▾
Cash Flow & Enterprise
FCF?$116.0K
Enterprise Value?$44.4M
Fundamentals ratios updated end of day